. 1% and a DCR of 95. 5%> • In terms of safety: During the dose exploration phase, one case of DLT with grade 4 thrombocytopenia occurred at 240 mg of APG-1252 .
Jingfeng Pharmaceuticals is expected to lose 850 million yuan in 2019
Time of Update: 2021-03-06
555.00% to 447.94 percent from a year earlier. Jingfeng Pharmaceuticals said that in 2019, in the drug bidding price reduction, the state focus on monitoring the introduction of rational drug use drug catalog, "4 plus 7" drug
Where is the hard time for China's pharmaceutical industry in 2019 when old dividends are exhausted?
Time of Update: 2021-03-04
-consistent varieties prices are expected to drop significantly, the third round of the national volume procurement policy seems more likely to come up with lower prices and more fragmented market, Wuhan Jiangxi Hebei and other places on the non
The loss of the Yushatan storm is serious, can Huahai Pharmaceuticals get out of the difficult situation in 2019?
Time of Update: 2021-03-04
, the company announced in its earnings report that it was ending its tradition of continuing dividends since it went public in 2003. to mention the loss of more than 400 million yuan Huahai Pharmaceuticals' current business
Sansheng Pharmaceuticals' first half 2019 results were announced
Time of Update: 2021-03-04
water needle (301S), and submitted the production batch to the State Drug Administration and received it. In the study of bio-oncology drug products - HER2, PD1, Antibodies such as EGFR have been steadily advancing: the anti-HER2
The 2019 Molecular Plant Breeding Conference was held in Jilin
Time of Update: 2021-02-25
July 3-4, the 2019 Molecular Plant Breeding Conference was held in Changchun, Jilin Province. With the theme of "practicing molecular breeding and promoting the innovation of the breeding industry", the conference set up three seminars
1 Pharmaceutical Network Q3 revenue increased 112.8% YoY In the first three quarters of the cumulative revenue exceeded the full year 2019
Time of Update: 2021-01-18
On the one hand, 1 drug network through innovative intelligent supply chain technology, Q3 tracking cost ratio fell to 2.5%, the lowest after the market; note: There are deletions in the original text
in the 2020 National Pharmaceutical Economic Information Conference of the latest forecast
Time of Update: 2020-12-28
prescription drugs, consumers actively asked U.S. retail giant CVS pharmacies to transfer personal prescription drug records to Amazon, Novarca, Lilly, BMS and other multinational pharmaceutical companies also in this year's Expo, with Ali Health and other
Reding Pharmaceuticals won the "2019 Pudong New Area high-growth enterprises outstanding contribution to the top 20"
Time of Update: 2020-12-18
the leadership of the new district. Biopharmaceuticals is one of the six major 100 billion-scale hard-core industries in Pudong New Area, as an outstanding representative of Pudong Biopharmaceutical Industry, and then Ding Pharmaceuticals makes full
Shanghai Fermentation Exhibition Conference Preview: Difficult Analysis Seminar
Time of Update: 2020-12-01
and transformation projects has become a challenge for pharmaceutical companies. How to introduce quality from the concept of design in new projects, based on risk and science of project planning, design, construction, certification, etc., to ensure
On the convening of the "2019 China Paint Conference" pre-notice - a tribute to the 40th anniversary of reform and opening up
Time of Update: 2020-11-22
About the 2019 China Paint Conference Pre-Notice - Tribute to the 40th Anniversary of Reform and Opening-up Date 2019-03-26 to 2019-03-28 City Puyang Address Henan Province Puyang Ying Hotel, Puyang
Yulilian Group held a grand 2019 supply and marketing conference
Time of Update: 2020-11-20
and specific requirements. He carefully analyzed the international and domestic titanium dioxide market and the company's industry position, requiring all supply and marketing personnel must make good use of the advantages of long-term group titanium dioxide
